Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?

Precision immunotherapy is a crucial approach to improve the efficacy of anti-cancer treatments, particularly in the metastatic setting. In this respect, accurate patient selection takes advantage of the multidimensional integration of patients’ clinical information and tumour-specific biomarkers st...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajjadi, Elham, Venetis, Konstantinos, Scatena, Cristian, Fusco, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864694/
https://www.ncbi.nlm.nih.gov/pubmed/33574895
http://dx.doi.org/10.3332/ecancer.2020.1150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864694/
https://www.ncbi.nlm.nih.gov/pubmed/33574895
http://dx.doi.org/10.3332/ecancer.2020.1150

Ejemplares similares